Part B Insider - 2014 Issue 11
Reader Question: Check With the Payer When Reporting Urine Drug Screening
Subscribe or sign in to view the full article.
Article Overview
This article addresses a reader question about reporting urine drug screening when a specimen is collected in the office and sent for laboratory testing. It discusses the general drug testing code families involved, notes payer-specific reporting differences, and highlights the importance of verifying coverage and billing guidance before submitting claims. The content is aimed at coders and billing staff working with laboratory and office-based drug testing claims.
Why This Topic Matters
Urine drug testing claims can vary by payer and test methodology, so understanding the applicable code set and coverage differences helps reduce denials and improper billing. The article is especially relevant for practices that perform point-of-care collection or send specimens to a reference laboratory.
What You Will Learn
- How urine drug screening reporting is affected by payer-specific policies
- Which general drug testing code families are discussed for office-based and laboratory-related services
- Why Medicare coverage considerations matter for these claims
- Why verification with the payer is important before claim submission
Who Should Read This
- Medical coders
- Billing specialists
- Revenue cycle staff
- Clinical practice staff involved in laboratory billing
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com